Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$492M |
| 2 |
LLL
L3 Technologies, Inc.
LLL
|
+$392M |
| 3 |
Apple
AAPL
|
+$245M |
| 4 |
AGN
Allergan plc
AGN
|
+$238M |
| 5 |
NXP Semiconductors
NXPI
|
+$226M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$568M |
| 2 |
Coty
COTY
|
+$491M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$224M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$211M |
| 5 |
Sysco
SYY
|
+$208M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.43% |
| 2 | Healthcare | 13.06% |
| 3 | Technology | 11.97% |
| 4 | Financials | 10.69% |
| 5 | Consumer Discretionary | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
PUT
MetLife
MET
$61.2B
| $3.13M | ﹤0.01% |
+63,000
| New | +$2.96M |
|
2102
The Joint Corp
JYNT
$120M
| $3.13M | ﹤0.01% |
171,719
+84,139
| +96% | +$1.43M |
|
|
CZR
2103
DELISTED
Caesars Entertainment Corporation
CZR
| $3.11M | ﹤0.01% |
262,900
-1,008,419
| -79% | -$9.55M |
|
|
CTT
2104
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
| $3.1M | ﹤0.01% |
297,157
+76,700
| +35% | +$763K |
|
2105
Tilly's
TLYS
$114M
| $3.1M | ﹤0.01% |
406,791
+188,562
| +86% | +$1.91M |
|
2106
PUT
Myriad Genetics
MYGN
$305M
| $3.1M | ﹤0.01% |
111,600
-98,400
| -47% | -$2.78M |
|
|
CTLT
2107
DELISTED
CATALENT, INC.
CTLT
| $3.1M | ﹤0.01% |
57,151
-15,538
| -21% | -$712K |
|
2108
MakeMyTrip
MMYT
$5.59B
| $3.09M | ﹤0.01% |
124,419
+34,326
| +38% | +$868K |
|
|
REV
2109
DELISTED
Revlon, Inc.
REV
| $3.08M | ﹤0.01% |
+159,590
| New | +$3.48M |
|
2110
Garrett Motion
GTX
$5.06B
| $3.08M | ﹤0.01% |
200,849
-396,069
| -66% | -$6.72M |
|
2111
CALL
State Street SPDR S&P Biotech ETF
XBI
$11.7B
| $3.07M | ﹤0.01% |
35,000
| – | – |
|
|
BNY
2112
Bank of New York Mellon
BNY
$111B
| $3.07M | ﹤0.01% |
69,442
-83,290
| -55% | -$3.91M |
|
|
CTST
2113
DELISTED
CannTrust Holdings Inc. Common Share
CTST
| $3.06M | ﹤0.01% |
+610,029
| New | +$3.73M |
|
|
WOW
2114
DELISTED
WideOpenWest
WOW
| $3.06M | ﹤0.01% |
420,899
+393,059
| +1,412% | +$3.2M |
|
2115
CALL
BioCryst Pharmaceuticals
BCRX
$2.48B
| $3.03M | ﹤0.01% |
800,000
+400,000
| +100% | +$2.41M |
|
|
LVOXU
2116
DELISTED
LiveVox Holding, Inc. Unit
LVOXU
| $3.03M | ﹤0.01% |
300,000
| – | – |
|
2117
PUT
US Bancorp
USB
$97.3B
| $3.02M | ﹤0.01% |
+57,700
| New | +$2.97M |
|
2118
PUT
eHealth
EHTH
$38.1M
| $3.01M | ﹤0.01% |
35,000
-65,000
| -65% | -$4.37M |
|
2119
State Street SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
$3.5B
| $3.01M | ﹤0.01% |
61,500
-2,147
| -3% | -$104K |
|
2120
Ituran Location and Control
ITRN
$1.03B
| $3M | ﹤0.01% |
99,837
+69,524
| +229% | +$2.34M |
|
2121
PUT
Zimmer Biomet
ZBH
$19.3B
| $3M | ﹤0.01% |
26,265
-56,135
| -68% | -$6.57M |
|
|
FOE
2122
DELISTED
Ferro Corporation
FOE
| $3M | ﹤0.01% |
189,900
-41,592
| -18% | -$668K |
|
2123
T-Mobile US
TMUS
$192B
| $3M | ﹤0.01% |
40,405
-91,879
| -69% | -$6.82M |
|
2124
International Paper
IP
$21.6B
| $3M | ﹤0.01% |
73,019
+47,380
| +185% | +$2.01M |
|
2125
CALL
Karyopharm Therapeutics
KPTI
$45.6M
| $3M | ﹤0.01% |
+33,333
| New | +$2.68M |
|
Similar funds
Israel Englander's Q2 2019 Portfolio in Review
As of Q2 2019, Israel Englander held 4,801 positions worth $66.5B, down 0.45% from $66.8B the previous quarter. Its ten largest holdings account for 7.7% of the portfolio.
Israel Englander withdrew a net $3.96B in Q2 2019, closing 810 positions and reducing 1,571 holdings. Its most notable exit was Sysco, an estimated $208M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, up from 18% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Israel Englander opened a new position in Moody's worth $125M.
- Israel Englander's largest Q2 2019 buy was Moody's: 638,271 shares worth $125M.
- Israel Englander added most to LyondellBasell Industries in Q2 2019, an estimated $492M increase.
- Israel Englander's biggest Q2 2019 reduction was Walt Disney, cutting an estimated $568M.
- Israel Englander fully exited Sysco in Q2 2019, selling an estimated $208M.
- Israel Englander's ten largest holdings make up 7.7% of its $66.5B portfolio in Q2 2019.
- Israel Englander opened 865 new positions and closed 810 in Q2 2019.
- Israel Englander's portfolio value fell 0.45% quarter-over-quarter to $66.5B.
Based on Millennium Management's 13F filing for Q2 2019, filed 14 Aug 2019.